Cargando…

Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma

BACKGROUND: In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus emerged in China and quickly spread into a worldwide pandemic. Prior to the development of specific drug therapies or a vaccine, more immediately available treatments were sought including convalescent p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandeberg, Peter, Cruz, Maria, Diez, Jose Maria, Merritt, W. Keither, Santos, Benjamin, Trukawinski, Susan, Wellhouse, Andrea, Jose, Marta, Willis, Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251388/ https://www.ncbi.nlm.nih.gov/pubmed/33715160 http://dx.doi.org/10.1111/trf.16378

Ejemplares similares

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins
por: Díez, José María, et al.
Publicado: (2021)

Caprylate/chromatography process to produce highly purified tetanus immune globulin from human plasma
por: Srivastava, Jyoti, et al.
Publicado: (2022)

Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
por: Basic-Jukic, Nikolina
Publicado: (2020)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
por: Chavda, Vivek P., et al.
Publicado: (2023)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial
por: Huygens, Sammy, et al.
Publicado: (2022)

GAMMA GLOBULIN TURNOVER IN RABBITS BEFORE AND DURING HYPERIMMUNIZATION
por: Andersen, Stig Bryde, et al.
Publicado: (1964)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Potent Anti‐SARS‐CoV‐2 Efficacy of COVID‐19 Hyperimmune Globulin from Vaccine‐Immunized Plasma
por: Yu, Ding, et al.
Publicado: (2022)

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
por: Keating, Sheila M., et al.
Publicado: (2021)

The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
por: Mair-Jenkins, John, et al.
Publicado: (2015)

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
por: Ali, Shaukat, et al.
Publicado: (2021)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
por: Mizrahi, Rena A., et al.
Publicado: (2022)

In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens
por: Rossmann, F. S., et al.
Publicado: (2014)

Biweekly Versus Monthly Hyperimmune Globulin Therapy for Primary Cytomegalovirus Infection in Pregnancy
por: Schirwani-Hartl, Nawa, et al.
Publicado: (2023)

RATES OF ANTIBODY SYNTHESIS DURING FIRST, SECOND, AND HYPERIMMUNE RESPONSES OF RABBITS TO BOVINE GAMMA GLOBULIN
por: Dixon, Frank J., et al.
Publicado: (1956)

Feasibility of identifying plasma donors with high measles neutralizing antibody concentrations for the use of producing a measles hyperimmune globulin for postexposure prophylaxis
por: Lackner, Cornelia, et al.
Publicado: (2022)

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
por: de Alwis, Ruklanthi, et al.
Publicado: (2020)

Cytomegalovirus mismatch after heart transplantation: Impact of antiviral prophylaxis and intravenous hyperimmune globulin
por: Immohr, Moritz B., et al.
Publicado: (2021)

Anti-SARS-CoV-2 hyperimmune plasma workflow
por: Annamaria, Petrungaro, et al.
Publicado: (2020)

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
por: Jungbauer, Christof, et al.
Publicado: (2020)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
por: Patel, Samir J., et al.
Publicado: (2014)

Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy
por: Nigro, Giovanni, et al.
Publicado: (2023)

Human Intramuscular Hyperimmune Gamma Globulin (hIHGG) Anti-SARS-CoV-2—Characteristics of Intermediates and Final Product
por: Lachert, Elzbieta, et al.
Publicado: (2022)

CMV hyperimmune globulin as salvage therapy for recurrent or refractory CMV infection in children undergoing hematopoietic stem cell transplantation
por: Panesso, Melissa, et al.
Publicado: (2023)

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus
por: LU, Jai‐hai, et al.
Publicado: (2005)

Plasma Donors in the Southwestern United States Positively Contribute to the Diverse Therapeutic Antibody Profile of Immune Globulin Products
por: Ciencewicki, Jonathan M., et al.
Publicado: (2020)

Detection of SARS‐CoV‐2‐independent immunoregulatory activity of COVID‐19 convalescent plasma
por: Brox, Regine, et al.
Publicado: (2021)

Absence of pathogenic viruses in COVID‐19 convalescent plasma
por: Kandathil, Abraham J., et al.
Publicado: (2022)

Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction
por: Lamikanra, Abigail, et al.
Publicado: (2021)

Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus‐specific hyperimmune globulin
por: Maximova, Natalia, et al.
Publicado: (2020)

Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell–Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy
por: Furlan, Anna, et al.
Publicado: (2021)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
por: Hanna, Kim, et al.
Publicado: (2018)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors
por: Dada, Ashraf, et al.
Publicado: (2022)

Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19
por: Biernat, Monika Maria, et al.
Publicado: (2021)

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')(2 )in mice
por: Lu, Jiahai, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_pvp3fvv0q6qv70tsucd7obntu4